Most material SEC filings — September 24, 2026

Christopher Jones resigned as CEO effective September 22, 2026. TruGolf committed to pay Jones: $100,000 severance; $1,444,000 loan repayment (10% by 30 days, 90% by 12 months, at 12% interest); $500,000 franchise-rights buyback (10% by 30 days, 90% by 12 months, at 12% interest); and $654,604 to the Audree Redd Jones Trust by September 30, 2026. Total fixed obligations: approximately $2.65M. All payments are independent of Jones's release of claims and unaffected by any failed transaction or financing.

Kyverna announced positive one-year topline data from KYSA-8 (26 SPS patients) showing sustained 49% median improvement in timed 25-foot walk, 95% maintained benefit, 92% remained off chronic immunotherapies, with no high-grade CRS/ICANS/IEC-HS. KYSA-6 Phase 2 (7 gMG patients) showed durable responses sustained to 1.5 years, 100% off immunosuppressants at 24 weeks, 86% off at last follow-up. Rolling BLA submission on track for Q4 2026; Phase 3 enrollment expected complete mid-2027.

Jaguar Health exchanged a portion of a promissory note (original principal amount redacted) issued to Streeterville Capital, LLC on November 12, 2025, for an unspecified number of common shares (both amounts blank in filing). The exchange occurred September 23, 2026, with shares issued free-trading and without restrictive legend. The Original Note balance was reduced by the partitioned amount; all other terms remain unchanged.